Loading insider details...
Beta
Latest Form 4 (Sep 3, 2026): Disposition to Issuer of 34,824 APGE shares.
Every alert includes an AI-written analysis of the filing, plus news and market context.
| Filed | Company | Transaction | Shares | Value |
|---|---|---|---|---|
| Sep 3, 2026 | Apogee Therapeutics, Inc. (APGE) | Disposition to Issuer | 34,824 | n/a |
| Aug 3, 2026 | Apnimed, Inc. (APMD) | Grant/Award | 44,477 | n/a |
| Jun 15, 2026 | Annexon, Inc. (ANNX) | Grant/Award | 65,000 | n/a |
| Jun 12, 2026 | Apogee Therapeutics, Inc. (APGE) | Grant/Award | 7,657 | n/a |
| Jun 21, 2025 | Apogee Therapeutics, Inc. (APGE) | Grant/Award | 14,461 | n/a |
| Jun 9, 2025 | Annexon, Inc. (ANNX) | Grant/Award | 55,000 | n/a |
| Jan 10, 2025 | Annexon, Inc. (ANNX) | Grant/Award | 88,000 | n/a |
| Jan 7, 2025 | NewAmsterdam Pharma Co N.V. (NAMS) | Grant/Award | 43,000 | n/a |
| Jan 6, 2025 | NewAmsterdam Pharma Co N.V. (NAMS) | Grant/Award | 200,000 | n/a |
| Jun 8, 2024 | Apogee Therapeutics, Inc. (APGE) | Grant/Award | 10,370 | n/a |